ESCO Announces Third Quarter Fiscal 2021 Results
“At the beginning of this fiscal year, we stated that with the strength of the first half of fiscal 2020 (pre-COVID), we projected the first half of fiscal 2021 to be slightly lower in comparison to 2020, and that we expected the second half of 2021 to be a favorable comparison to the prior year given our expectation of tangible elements of recovery. Due to our focus on effective cost management and program execution, our first half Adjusted EPS and Adjusted EBITDA exceeded the prior year on lower revenue (as presented in our
Discrete Items
During Q3 2021, the Company incurred
YTD 2021, the Company has incurred
During Q3 2020, the Company incurred
In the first nine months of 2020, the Company incurred
The financial results presented include certain non-GAAP financial measures such as Adjusted SG&A, EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS, as defined within the “Non-GAAP Financial Measures” described below. Any non-GAAP financial measures presented are reconciled to their respective GAAP equivalents. Management believes these non-GAAP financial measures are useful in assessing the ongoing operational profitability of the Company’s business segments, and therefore, allow shareholders better visibility into the Company’s underlying operations. See “Non-GAAP Financial Measures” described below.
Earnings Summary
Q3 2021 GAAP EPS was
YTD 2021 GAAP EPS was
Q3 2020 GAAP EPS was
YTD 2020 GAAP EPS from Continuing Operations was
Operating Highlights – Q3 & YTD
- Sales increased
$8 million (5 percent) to$181 million in Q3 2021, compared to$173 million in Q3 2020. YTD 2021 sales decreased$15 million (3 percent) to$510 million , compared to$525 million YTD 2020. - Gross margin percentage decreased to 37.4 percent in Q3 2021 from 37.6 percent in Q3 2020, due to the previously discussed issues at Westland, largely offset by the implementation of cost reduction actions across the company. YTD 2021 gross margin percentage increased to 37.9 percent from 37.6 percent in YTD 2020.
- Adjusted SG&A expenses increased by
$4.2 million in Q3 2021 compared to Q3 2020 due to overall lower operating expenses in the prior year related to COVID and the moderate return of travel and other expenses in 2021. Adjusted YTD 2021 SG&A expenses increased by$1.5 million compared to YTD 2020 due to the above, partially offset by lower spending (headcount, travel and pension) in the first half of the year. - Interest expense decreased
$1.0 million in Q3 2021 and$3.8 million YTD 2021 compared to the prior year due to lower debt outstanding and lower average interest rates. - The effective income tax rate increased to 21.3 percent in Q3 2021 from 14.3 percent in Q3 2020. The significantly lower tax rate in Q3 2020 reflected the favorable impact (
$0.06 per share) of certain one-time tax strategies implemented in the prior year which were not repeated. - Q3 2021 Entered orders were
$204 million (book-to-bill of 1.12x). YTD entered orders are$538 million (book-to-bill of 1.05x), and backlog has increased in all three business segments year-to-date. - YTD 2021 net cash provided by operating activities was
$75 million , resulting in a net cash position (total cash on hand, less total borrowings) of$30 million and a 0.43x leverage ratio atJune 30, 2021 .
Segment Performance
A&D
- Sales increased
$2 million (2 percent) to$86 million in Q3 2021 from$84 million in Q3 2020, due to higherNavy sales partially offset by lower commercial aerospace sales. While commercial aerospace weakness is continuing, increasedU.S domestic passenger boardings and recent orders for new planes by major airlines are encouraging signs for 2022. - Adjusted EBIT decreased
$1.5 million in Q3 2021 to$16.7 million from$18.2 million in Q3 2020, with a 20 percent Adjusted EBIT margin, as the Westland issues and continued softness in the commercial aerospace market were partially offset by higher contribution fromNavy programs. - Entered Orders were
$95 million in Q3 2021 (book-to-bill of 1.11) compared to$66 million in Q3 2020. With continued strength inNavy and space, and solid order growth in commercial aerospace, overall A&D orders increased$29 million (44 percent) in Q3.
USG
- Sales increased
$5 million (12 percent) to$48 million in Q3 2021 from$43 million in Q3 2020. Doble sales increased$3 million (8 percent), driven by growth from utility customers, although overall demand has not returned to pre-COVID levels. NRG sales increased$2 million (37 percent) with significant momentum in both wind and solar. - Adjusted EBIT increased
$2.4 million in Q3 2021 to$8.7 million from$6.3 million in Q3 2020, with an 18 percent EBIT margin versus 15 percent in the prior year. The profitability increase was driven by leverage on sales growth and favorable impacts from prior cost reductions. - Entered Orders were
$55 million in Q3 2021 (book-to-bill of 1.16) compared to$50 million in Q3 2020. Despite some continued deferrals of maintenance and test equipment purchases, electric utility orders were up$2 million (5 percent) and renewables orders were up$3 million (49 percent) over the prior year with significant growth in both solar and wind.
Test
- Sales increased
$2 million (5 percent) to$48 million in Q3 2021 from$46 million in Q3 2020, due to strength in theAmericas andEurope partially offset by lower sales inAsia . - EBIT decreased
$0.4 million in Q3 2021 to$6.8 million (compared to$7.2 million in Q3 2020), with a 14 percent EBIT margin. A strong quarter of sales with favorable mix inAsia drove the higher margin in the prior year. - Entered Orders were
$53 million in Q3 2021 (book-to-bill of 1.11) compared to$41 million in Q3 2020. The$12 million (28 percent) increase was primarily driven by strength inAsia and sets a strong backlog for Q4 and fiscal 2022.
Summary Commentary
Despite the continuing COVID related challenges, our Q3 sales and entered orders increased both sequentially and year-over-year across all three business segments. From a margin perspective, Q3 Adjusted EBITDA margin decreased to 18.2 percent from 20.3 percent in the prior year, primarily related to the Westland issues in the quarter, the return of travel and other spending in 2021, and lower operating expenses in 2020 related to COVID. Due to our persistent focus on cost management, YTD Adjusted EBITDA margins are in line with both 2020 and pre-COVID 2019 levels, giving us confidence in our ability to drive margin improvement as long-term revenue growth returns in our more challenged end-markets.
Driven by our continuing focus on working capital management and cash conversion, our cash flow from operations is up
New Share Repurchase Program
On
Dividend Payment
The next quarterly cash dividend of
Business Outlook – 2021
Throughout the first nine months of 2021, our
While we did see good order input and sales growth for all three segments in Q3, the level of activity is somewhat lower than anticipated in the commercial aerospace and utility markets. Backlog is building to support significant improvement in fiscal 2022. Our expectation is for solid Q4 growth in sales, Adjusted EBITDA, and Adjusted EPS as compared to Q3 2021. However, with the recovery of commercial aerospace still in the early stages, we do not anticipate the level of revenue strength we typically see in our fourth quarter. Our expectation is for Q4 Adjusted EPS to be in the range of
Conference Call
The Company will host a conference call today,
Forward-Looking Statements
Statements in this press release regarding the timing and magnitude of recovery in the Company’s end markets, the continuing impacts of COVID-19 on the Company’s results, sales, Adjusted SG&A, Adjusted EBIT, Adjusted EBITDA, Adjusted EPS, cash flow, results of cost reduction efforts, margins, growth, the financial success of the Company, the strength of its end markets, the outlook for the A&D, Test and USG segments, the ability to increase shareholder value, the timing and success of acquisition efforts, internal investments in new products and solutions, the correction of production issues, the effect of certain changes in the Company’s internal controls or in other factors on the effectiveness of its internal controls, the long-term success of the Company, and any other statements which are not strictly historical are “forward-looking” statements within the meaning of the safe harbor provisions of the federal securities laws.
Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
The financial measures Adjusted SG&A, EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS are presented in this press release. The Company defines “Adjusted SG&A” as the corresponding GAAP amounts excluding the net impact of the items described above in Discrete Items and reconciled in the attached Reconciliation of Non-GAAP Financial Measures, “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described above in Discrete Items, and “Adjusted EPS” as GAAP earnings per share (EPS) excluding the net impact of the items described above which were (
Adjusted SG&A, EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS are not recognized in accordance with
ESCO, headquartered in
Condensed Consolidated Statements of Operations (Unaudited) | ||||||||||||
(Dollars in thousands, except per share amounts) | ||||||||||||
Three Months Ended |
Three Months Ended |
|||||||||||
$ | 181,394 | 172,665 | ||||||||||
Cost and Expenses: | ||||||||||||
Cost of sales | 113,610 | 107,686 | ||||||||||
Selling, general and administrative expenses | 42,882 | 36,936 | ||||||||||
Amortization of intangible assets | 4,864 | 5,535 | ||||||||||
Interest expense | 480 | 1,523 | ||||||||||
Other (income) expenses, net | 615 | (824 | ) | |||||||||
Total costs and expenses | 162,451 | 150,856 | ||||||||||
Earnings before income taxes | 18,943 | 21,809 | ||||||||||
Income tax expense | 4,034 | 3,122 | ||||||||||
Net earnings | $ | 14,909 | 18,687 | |||||||||
Diluted EPS: | ||||||||||||
Diluted - GAAP | ||||||||||||
Net earnings | $ | 0.57 | 0.72 | |||||||||
Diluted - As Adjusted Basis | ||||||||||||
Continuing operations | $ | 0.67 | (1 | ) | 0.76 | (2 | ) | |||||
Diluted average common shares |
26,214 | 26,134 | ||||||||||
(1 | ) | Q3 2021 Adjusted EPS excludes |
||||||||||
(2 | ) | Q3 2020 Adjusted EPS excludes |
Condensed Consolidated Statements of Operations (Unaudited) | |||||||||||||
(Dollars in thousands, except per share amounts) | |||||||||||||
Nine Months Ended |
Nine Months Ended |
||||||||||||
$ | 509,962 | 524,885 | |||||||||||
Cost and Expenses: | |||||||||||||
Cost of sales | 316,785 | 327,655 | |||||||||||
Selling, general and administrative expenses | 122,628 | 119,023 | |||||||||||
Amortization of intangible assets | 14,729 | 16,565 | |||||||||||
Interest expense | 1,453 | 5,264 | |||||||||||
Other (income) expenses, net | (1,265 | ) | 174 | ||||||||||
Total costs and expenses | 454,330 | 468,681 | |||||||||||
Earnings before income taxes | 55,632 | 56,204 | |||||||||||
Income tax expense | 12,501 | 8,931 | |||||||||||
Earnings from continuing operations | 43,131 | 47,273 | |||||||||||
(Loss) earnings from discontinued operations, net of tax | |||||||||||||
expense of |
- | (601 | ) | ||||||||||
Gain on sale of discontinued operations, net of | |||||||||||||
tax expense of |
- | 76,614 | |||||||||||
Earnings from discontinued operations | - | 76,013 | |||||||||||
Net earnings | $ | 43,131 | 123,286 | ||||||||||
Diluted EPS: | |||||||||||||
Diluted - GAAP | |||||||||||||
Continuing operations | $ | 1.65 | 1.81 | ||||||||||
Discontinued operations | 0.00 | 2.91 | |||||||||||
Net earnings | $ | 1.65 | 4.72 | ||||||||||
Diluted - As Adjusted Basis | |||||||||||||
Continuing operations | $ | 1.75 | (1 | ) | 1.87 | (2 | ) | ||||||
Diluted average common shares |
26,199 | 26,130 | |||||||||||
(1 | ) | YTD Q3 2021 Adjusted EPS excludes |
|||||||||||
(2 | ) | YTD Q3 2020 Adjusted EPS excludes |
Condensed Business Segment Information (Unaudited) | |||||||||||||||
(Dollars in thousands) | |||||||||||||||
GAAP | As Adjusted | ||||||||||||||
Q3 2021 | Q3 2020 | Q3 2021 | Q3 2020 | ||||||||||||
Aerospace & Defense | $ | 85,576 | 84,072 | 85,576 | 84,072 | ||||||||||
USG | 47,704 | 42,577 | 47,704 | 42,577 | |||||||||||
Test | 48,114 | 46,016 | 48,114 | 46,016 | |||||||||||
Totals | $ | 181,394 | 172,665 | 181,394 | 172,665 | ||||||||||
EBIT | |||||||||||||||
Aerospace & Defense | $ | 16,714 | 17,409 | 16,739 | 18,224 | ||||||||||
USG | 8,227 | 6,156 | 8,710 | 6,316 | |||||||||||
Test | 6,751 | 7,177 | 6,751 | 7,246 | |||||||||||
Corporate | (12,269 | ) | (7,410 | ) | (9,246 | ) | (7,219 | ) | |||||||
Consolidated EBIT | 19,423 | 23,332 | 22,954 | 24,567 | |||||||||||
Less: Interest expense | (480 | ) | (1,523 | ) | (480 | ) | (1,523 | ) | |||||||
Less: Income tax expense | (4,034 | ) | (3,122 | ) | (4,846 | ) | (3,418 | ) | |||||||
Net earnings from cont ops | $ | 14,909 | 18,687 | 17,628 | 19,626 | ||||||||||
Note 1: Adjusted net earnings were |
|||||||||||||||
Note 2: Adjusted net earnings were |
|||||||||||||||
EBITDA Reconciliation to Net earnings from continuing operations: | |||||||||||||||
Adjusted | Adjusted | ||||||||||||||
Q3 2021 | Q3 2020 | Q3 2021 | Q3 2020 | ||||||||||||
Consolidated EBITDA | $ | 29,567 | 33,815 | 33,098 | 35,050 | ||||||||||
Less: Depr & Amort | (10,144 | ) | (10,483 | ) | (10,144 | ) | (10,483 | ) | |||||||
Consolidated EBIT | 19,423 | 23,332 | 22,954 | 24,567 | |||||||||||
Less: Interest expense | (480 | ) | (1,523 | ) | (480 | ) | (1,523 | ) | |||||||
Less: Income tax expense | (4,034 | ) | (3,122 | ) | (4,846 | ) | (3,418 | ) | |||||||
Net earnings from cont ops | $ | 14,909 | 18,687 | 17,628 | 19,626 | ||||||||||
Condensed Business Segment Information (Unaudited) | |||||||||||||||
(Dollars in thousands) | |||||||||||||||
GAAP | As Adjusted | ||||||||||||||
YTD Q3 | YTD Q3 | YTD Q3 | YTD Q3 | ||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Aerospace & Defense | $ | 234,720 | 256,707 | 234,720 | 256,707 | ||||||||||
USG | 141,799 | 139,179 | 141,799 | 139,179 | |||||||||||
Test | 133,443 | 128,999 | 133,443 | 128,999 | |||||||||||
Totals | $ | 509,962 | 524,885 | 509,962 | 524,885 | ||||||||||
EBIT | |||||||||||||||
Aerospace & Defense | $ | 41,980 | 51,658 | 42,365 | 52,543 | ||||||||||
USG | 27,683 | 20,310 | 27,552 | 21,090 | |||||||||||
Test | 17,781 | 17,483 | 17,781 | 17,552 | |||||||||||
Corporate | (30,359 | ) | (27,983 | ) | (26,986 | ) | (27,792 | ) | |||||||
Consolidated EBIT | 57,085 | 61,468 | 60,712 | 63,393 | |||||||||||
Less: Interest expense | (1,453 | ) | (5,264 | ) | (1,453 | ) | (5,264 | ) | |||||||
Less: Income tax | (12,501 | ) | (8,931 | ) | (13,335 | ) | (9,393 | ) | |||||||
Net earnings from cont ops | $ | 43,131 | 47,273 | 45,924 | 48,736 | ||||||||||
Note 1: Adjusted net earnings were |
|||||||||||||||
Note 2: Adjusted net earnings were |
|||||||||||||||
EBITDA Reconciliation to Net earnings from continuing operations: | |||||||||||||||
Adjusted | Adjusted | ||||||||||||||
YTD Q3 | YTD Q3 | YTD Q3 | YTD Q3 | ||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Consolidated EBITDA | $ | 87,344 | 92,534 | 90,971 | 94,459 | ||||||||||
Less: Depr & Amort | (30,259 | ) | (31,066 | ) | (30,259 | ) | (31,066 | ) | |||||||
Consolidated EBIT | 57,085 | 61,468 | 60,712 | 63,393 | |||||||||||
Less: Interest expense | (1,453 | ) | (5,264 | ) | (1,453 | ) | (5,264 | ) | |||||||
Less: Income tax expense | (12,501 | ) | (8,931 | ) | (13,335 | ) | (9,393 | ) | |||||||
Net earnings from cont ops | $ | 43,131 | 47,273 | 45,924 | 48,736 | ||||||||||
|
||||||
Condensed Consolidated Balance Sheets (Unaudited) | ||||||
(Dollars in thousands) | ||||||
2021 |
2020 |
|||||
Assets | ||||||
Cash and cash equivalents | $ | 78,359 | 52,560 | |||
Accounts receivable, net | 135,343 | 144,082 | ||||
Contract assets | 94,768 | 94,302 | ||||
Inventories | 141,113 | 135,296 | ||||
Other current assets | 21,282 | 17,053 | ||||
Total current assets | 470,865 | 443,293 | ||||
Property, plant and equipment, net | 141,967 | 139,870 | ||||
Intangible assets, net | 343,346 | 346,632 | ||||
411,732 | 408,063 | |||||
Operating lease assets | 30,426 | 21,390 | ||||
Other assets | 10,347 | 10,938 | ||||
$ | 1,408,683 | 1,370,186 | ||||
Liabilities and Shareholders' Equity | ||||||
Current maturities of long-term debt & short-term borrowings | $ | 20,000 | 22,368 | |||
Accounts payable | 50,921 | 50,525 | ||||
Contract liabilities | 105,822 | 100,551 | ||||
Other current liabilities | 76,649 | 82,585 | ||||
Total current liabilities | 253,392 | 256,029 | ||||
Deferred tax liabilities | 56,992 | 60,170 | ||||
Non-current operating lease liabilities | 26,458 | 16,785 | ||||
Other liabilities | 38,987 | 38,176 | ||||
Long-term debt | 28,000 | 40,000 | ||||
Shareholders' equity | 1,004,854 | 959,026 | ||||
$ | 1,408,683 | 1,370,186 |
Consolidated Statements of Cash Flows (Unaudited) | ||||||
(Dollars in thousands) | ||||||
Nine Months Ended |
Nine Months Ended |
|||||
Cash flows from operating activities: | ||||||
Net earnings | $ | 43,131 | 123,286 | |||
Earnings from discontinued operations | - | (76,013 | ) | |||
Adjustments to reconcile net earnings to net cash | ||||||
provided by operating activities: | ||||||
Depreciation and amortization | 30,259 | 31,066 | ||||
Stock compensation expense | 5,386 | 4,184 | ||||
Changes in assets and liabilities | 2,520 | (20,926 | ) | |||
Gain on sale of building and land | (1,950 | ) | - | |||
Effect of deferred taxes | (3,946 | ) | 2,155 | |||
Pension contributions related to terminated pension plan | - | (10,000 | ) | |||
Net cash provided by operating activities - continuing operations | 75,400 | 53,752 | ||||
Net cash used by operating activities - discontinued operations | - | (14,737 | ) | |||
Net cash provided by operating activities | 75,400 | 39,015 | ||||
Cash flows from investing activities: | ||||||
Acquisition of business, net of cash acquired | (6,684 | ) | - | |||
Proceeds from sale of building and land | 1,950 | - | ||||
Capital expenditures | (17,887 | ) | (28,291 | ) | ||
Additions to capitalized software | (6,500 | ) | (6,564 | ) | ||
Net cash used by investing activities - continuing operations | (29,121 | ) | (34,855 | ) | ||
Proceeds from sale of discontinued operations | - | 183,812 | ||||
Capital expenditures - discontinued operations | - | (1,728 | ) | |||
Net cash provided by investing activities - discontinued operations | - | 182,084 | ||||
Net cash (used) provided by investing activities | (29,121 | ) | 147,229 | |||
Cash flows from financing activities: | ||||||
Proceeds from long-term debt and short-term borrowings | 80,000 | 11,577 | ||||
Principal payments on long-term debt and short-term borrowings | (94,368 | ) | (145,000 | ) | ||
Dividends paid | (6,249 | ) | (6,240 | ) | ||
Other | (1,674 | ) | (3,127 | ) | ||
Net cash used by financing activities - continuing operations | (22,291 | ) | (142,790 | ) | ||
Net cash used by financing activities - discontinued operations | - | (2,140 | ) | |||
Net cash used by financing activities | (22,291 | ) | (144,930 | ) | ||
Effect of exchange rate changes on cash and cash equivalents | 1,811 | 1,617 | ||||
Net increase in cash and cash equivalents | 25,799 | 42,931 | ||||
Cash and cash equivalents, beginning of period | 52,560 | 61,808 | ||||
Cash and cash equivalents, end of period | $ | 78,359 | 104,739 |
Other Selected Financial Data (Unaudited) | ||||||||||||||
(Dollars in thousands) | ||||||||||||||
Backlog And Entered Orders - Q3 2021 | Aerospace & Defense | USG | Test | Total | ||||||||||
Beginning Backlog - |
$ | 349,165 | 48,943 | 118,424 | 516,532 | |||||||||
Entered Orders | 95,145 | 55,476 | 53,228 | 203,849 | ||||||||||
Sales | (85,576 | ) | (47,704 | ) | (48,114 | ) | (181,394 | ) | ||||||
Ending Backlog - |
$ | 358,734 | 56,715 | 123,538 | 538,987 | |||||||||
Backlog And Entered Orders - YTD Q3 2021 | Aerospace & Defense | USG | Test | Total | ||||||||||
Beginning Backlog - |
$ | 344,661 | 50,688 | 115,854 | 511,203 | |||||||||
Entered Orders | 248,793 | 147,826 | 141,127 | 537,746 | ||||||||||
Sales | (234,720 | ) | (141,799 | ) | (133,443 | ) | (509,962 | ) | ||||||
Ending Backlog - |
$ | 358,734 | 56,715 | 123,538 | 538,987 |
Reconciliation of Non-GAAP Financial Measures (Unaudited) | ||||||||
Adjusted Basis Reconciliation - Q3 2021 | SG&A | EPS | ||||||
GAAP Basis | 42,882 | $ | 0.57 | |||||
Adjustments | ||||||||
Management Transition & Acquisition Costs | (3,023 | ) | $ | 0.09 | ||||
USG ( |
- | $ | 0.01 | |||||
Total Adjustments | (3,023 | ) | $ | 0.10 | ||||
As Adjusted Basis | 39,859 | $ | 0.67 | |||||
The |
||||||||
Adjusted Basis Reconciliation – YTD Q3 2021 | SG&A | EPS | ||||||
GAAP Basis | 122,628 | $ | 1.65 | |||||
Adjustments | ||||||||
Management Transition & Acquisition Costs | (3,373 | ) | $ | 0.10 | ||||
ATM Acquisition Inventory Step-up Charge | $ | 0.01 | ||||||
USG (Manta & |
- | $ | 0.05 | |||||
Settlement from Doble Watertown Facility Sale | - | ($ | 0.06 | ) | ||||
Total Adjustments | (3,373 | ) | $ | 0.10 | ||||
As Adjusted Basis | 119,255 | $ | 1.75 | |||||
The |
||||||||
Adjusted Basis Reconciliation – Q3 2020 | SG&A | EPS | ||||||
EPS from Continuing Ops – GAAP Basis | 36,936 | $ | 0.72 | |||||
Adjustments (defined below) | (1,235 | ) | $ | 0.04 | ||||
EPS from Continuing Ops – As Adjusted Basis | 35,701 | $ | 0.76 | |||||
Adjustments exclude |
||||||||
Adjusted Basis Reconciliation – YTD Q3 2020 | SG&A | EPS | ||||||
EPS from Continuing Ops – GAAP Basis | 119,023 | $ | 1.81 | |||||
Adjustments (defined below) | (1,235 | ) | $ | 0.06 | ||||
EPS from Continuing Ops – As Adjusted Basis | 117,788 | $ | 1.87 | |||||
Adjustments exclude |
SOURCE
ESCO Technologies Inc.